Neurotrophic Keratitis: New Approaches to Manage Disease and Improve Patient Satisfaction

Supported through an unrestricted educational grant from Dompé.

Learning Objectives

At the completion of this educational activity, the participating ophthalmologist will be better able to:

• Describe the stages of neurotrophic keratitis and how to differentiate it from similar diseases.
• Recognize the various potential causes of neurotrophic keratitis.
• Understand the mechanisms of action of newer treatments and when they should be introduced into treatment regimens for neurotrophic keratitis.
• Identify the relationships between disease characteristics, drugs, treatment frequency, visual, and anatomic outcomes.

Accreditation and Designation Statement

Provided by Evolve Medical Education

Accreditation Statement
Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
Evolve designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This course is COPE approved for 1.0 hour of CE credit for optometrists.

Sponsored by  

Evolve is an approved COPE administrator.

COPE Course ID: 67919-AS
COPE Event ID: 119360

Faculty and Disclosures

MARJAN FARID, MD
Professor of Ophthalmology, School of Medicine
Vice Chair of Ophthalmic Faculty
Director, Cornea/External Disease, Cataract and Refractive Surgery
Gavin Herbert Eye Institute, UC Irvine
Irvine, California

TERRY KIM, MD
Professor of Ophthalmology
Duke University School of Medicine
Chief, Cornea and External Disease Division
Director, Refractive Surgery Service
Duke University Eye Center
Durham, North Carolina

FRANCIS S. MAH, MD
Director, Cornea and External Disease
Co-Director, Refractive Surgery
Scripps Clinic
La Jolla, California

DISCLOSURE POLICY

It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

Marjan Farid, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Biotissue, CorneaGen, and Novartis. Grant/Research Support: Allergan, Dompé, and Johnson & Johnson Vision.

Francis S. Mah, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Dompé.

Terry Kim, MD, and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie Pharmaceuticals, Alcon, Allergan, Avedro, Avellino Labs, Bausch + Lomb, Blephex, CorneaGen, Dompé, Eyenovia, Johnson & Johnson Vision, Kala Pharmaceuticals, Novabay Pharmaceuticals, Novartis, Ocular Therapeutix, Omeros, Presbyopia Therapies, Shire, Sight Sciences, Simple Contacts, Surface, and Zeiss.

Editorial Support

The Evolve staff and planners have no financial relationships with commercial interests.

Virginia Pickles, writer, and Nisha Mukherjee, MD, peer reviewer, have no financial relationships with commercial interests.

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Cataract & Refractive Surgery Today, Modern Optometry, or Dompé.